NME2 and gastric cancer: The results demonstrated that the NME2 knockdown led to cell cycle arrest in G1 phase, while the cell cycle of NME2-rescued cells was similar to that of the wild-type cells (Fig. 4d), showing that the NME2 silencing suppressed the proliferation of gastric cancer stem-like cells.